Dr Alphonse Ouédraogo (ORCID 0000-0002-3520-6637) is a physician working in malaria research for over 15 years. Working with the Groupe de Recherche Action en Santé (GRAS), Alphonse has co-authored more than 60 articles in peer-reviewed journals. He has conducted numerous phase I to IV clinical trials in malaria research, leading a team of clinical researchers. His current research focuses on malaria prevention (trials of candidate malaria vaccines and epidemiological studies to better understand the dynamics of malaria transmission), the discovery of antimalarial drugs, and studies of the pharmacokinetics and pharmacodynamics of antimalarial drugs.

Nomenjanahary Rakotondrandriana Antsa (ORCID 0000-0002-6890-9152) is a doctorv specialising in public health. She is particularly interested in clinical research and epidemiology and works in the Clinical Trials Department of the National Centre for Pharmaceutical Research Applications (CNARP) as a clinical trial investigator.

Ange-Carmelle Kankurize is the communications officer at INSP. After studying Information and Communication Technology at the Polytechnic University of Gitega, she began her career in radio as a journalist and presenter. With her wealth of experience in communications and journalism, she now puts her skills to work at the National Institute of Public Health in Burundi.

Claude Arsène Ratsimbasoa, MD, PhD, is an epidemiologist with a degree in medicine from the University of Antananarivo, Madagascar, and a PhD in epidemiology from Victor Segalen University, Bordeaux 2, France. His expertise focuses primarily on clinical research in malaria. Since 2013, he has been a senior lecturer and in 2013 becamse a full professor at the Unitersity of Antananarivo. His articles have been cited 2,700 times.

Bob Taylor is an Emeritus Consultant in Infectious Diseases for Oxford University NHS Trust, (ORCID 0000-0001-6236-0464) and currently works as a clinical researcher at the University of Oxford. He is a specialist in tropical medicine and also a visiting physician at Geneva University Hospital. His research focuses on conducting clinical trials on P. falciparum and P. vivax malaria, with a particular interest in the efficacy and safety of primaquine. He has been awarded numerous grants and, together with Dr Julie Nguyen Ngoc P, has obtained EDCTP funding for the DPP (Development of Paediatric Primaquine) and IMPRIMA (Implementation of Primaquine SLDPQ) projects.
Bob Taylor obtained his Doctor of Medicine at Guy's Hospital in London in 1981. He acquired extensive clinical experience in the United Kingdom, Zimbabwe, Swaziland (Eswatini), Hong Kong and the United States. His research career began in 1995, when he spent three years in Indonesia conducting clinical studies on malaria prophalyaxis and treatment. He then worked for eight years at the World Health Organization as part of the TDR programme, where he managed multicentre clinical trials of artemisinin-based combination therapies (ACT). This led to the WHO making its recommendation for ACTs as first-line treatments in the treatment of falciparum malaria and the prequalification of the ACTs – artemisinin-amodiaquine and artesunate-mefloquine.
Bob Taylor is currently a registered specialist in tropical diseases with the Medical Council of the United Kingdom and Switzerland.

Fanambinantsoa Claude Andrianaivoniaina is a computer scientist specialising in software development and database management. He holds a Higher Professional Studies Diploma (DESP) in Computer Science and works at CNARP as a clinical database manager. A former computer scientist at MESUPRES, he has expertise in programming, IT maintenance, system administration and networking.

Denis Niyomwungere holds a Doctorate from the University of Burundi and a Masters in bioinformatics from the African Centre of Excellence in Bioinformatics in Mali. A specialist in malariology, Denis is dedicated to monitoring resistance in antimalarials at both the national and international level. He serves as a resource person for the National Malaria Control Programme and is involved in several research projects, including IMPRIMA, where he is project manager in Burundi and co-principal investigator. Denis currently works as a lecturer, researcher and head of data management at INSP, where he actively contributes to malaria research. He is also currently undertaking a PhD in clinical epidemiology at the University of Strasbourg, France.

Denise Hien (ORCID 0000-0002-7073-6924) holds a Master's degree in Sociology and a Master's degree in Social and Cultural Anthropology. She is currently a PhD student in Health Sociology at Joseph Ki Zerbo University in Ouagadougou (Burkina Faso). She has been working as a sociologist with the Groupe de Recherche Action en Santé (GRAS) in Burkina Faso since 2018. As head of the institution's social sciences department, she plays a key role in conducting studies, mobilising and engaging communities. As part of the IMPRIMA programme, Denise Hien is responsible for the socio-anthropological studies on malaria and primaquine in Burkina Faso.

Didier Ménard, pharmacist and Doctor of Science (ORCID 0000-0003-1357-4495), has dedicated his career to the study of malaria and antimalarial resistance. After heading several units in the international network of Pasteur Institutes in New Caledonia, Central African Republic, Madagascar and Cambodia, he became a professor at the University of Strasbourg and a visiting researcher at the Pasteur Institute in Paris. His research has revealed key mechanisms of Plasmodium falciparum resistance in antimalarial drugs. He has received several prestigious awards and authored more than 230 publications. Didier serves as the Principal Investigator and Coordinator of the IMPRIMA project for UNISTRA.

Emmanuelle Caspar (ORCID 009-0006-5823-2922) joined the IMPRIMA project coordination team in May 2023 as Project Manager. A research engineer with degrees in Infectiology and Project Management, she is part of the Malaria Genetics & Resistance team (Research Unit 3073) at the Institute of Bacteriology and Parasitology of the Faculty of Medicine of Strasbourg. Her work focuses on public health and applied research, with a particular emphasis on studying and monitoring the emergence of Plasmodium falciparum resistance to antimalarial drugs. She provides cross-functional support to partners in administrative, technical and financial matters, and acts as liaison between the consortium and funders – GH EDCTP3 JU.

Fabrice Ruiz is the CEO of ClinSearch, a Clinical Research Organization he co-founded in 1999. ClinSearch conducts clinical and epidemiological studies but also develops its own R&D programmes for the analysis of large databases and the modeling of multidimensional concepts. He is also the CEO of Imisca Therapeutics, a start-up founded in 2020 for developing a new treatment in immune-oncology.
From an academic point of view, Fabrice is a member of the board of Ecole de Biologie Industrielle. He is an active member of EuPFI (European Paediatric Formulation Initiative) and is also a member of various expert groups such as Smart Health Strategic Value Chain (European Commission), Health Technology Assessment (Conect4children) and Formulation (Conect4children), and the R2G group of the Assistance Publique des Hôpitaux de Paris which conducts research on galenic and geriatric therapeutic issues.

Helena Prado is a social and cultural anthropologist at the École des Hautes Études en Sciences Sociales (EHESS). Helena Prado (ORCID 0000-0002-0270-2167) is also a senior lecturer in anthropology at the University of Strasbourg (Institute of Ethnology, Faculty of Social Sciences/Interdisciplinary Laboratory for Cultural Studies), where she teaches in the departments of social sciences and health studies. Since 2017, she has been conducting research in health anthropology, particularly on representations of body, reproductive and sexual life, and the social management of vector-borne diseases (Zika, malaria).

Photo : Catherine Schröder/University of Strasbourg

Jackie Andriarison N. holds a degree in Communication and Media from the Faculty of Arts and Humanities in Antananarivo. Passionate about communication, she also trained in economic journalism and organisational communication, and recently obtained a certificate in Community Management. She holds the position of communications manager at the National Centre for the Application of Pharmaceutical Research (CNARP).

Jean-Baptiste Bibié Yaro (ORCID 0009-0009-5503-4316) holds a Doctorate in Medicine from the University of Ouagadougou (Burkina Faso), a Master's degree in Clinical Research from the Medical University of Vienna (Austria) and a Doctorate in Epidemiology of Biomedical Sciences from the University of Durham (United Kingdom). His research has contributed to furthering understanding of risk factors, transmission and impact of malaria control tools in children and pregnant women in Burkina Faso. His doctoral research was part of the MIRA project, which studied the impacts of insecticide resistance on current malaria control tools in Burkina Faso. This research led to additional interventions needed to improve malaria control, such as Seasonal Malaria Chemoprevention (SMC) and improving household living conditions. Jean-Baptiste has participated in several clinical trials for the development of malaria drugs (phases I to IV) and vaccines (phases I and IIb). The results of his previous research on SSP in children have been used by the WHO in its SSP recommendations. This research has been continued and extended to older children as part of the INDIE-SMC project to assess the direct and indirect impact on community malaria transmission. He is Co-Investigator for the implementation and impact assessment of the reduction of community transmission of malaria with low-dose primaquine recommended by the WHO in patients with uncomplicated Plasmodium falciparum malaria in Burkina Faso, Burundi and Madagascar.

Joseph Nyandwi is Associate Professor of Nephrology at the University of Burundi and Director General of the National Institute of Public Health of Burundi. He obtained his PhD in Nephrology from the University of Burundi and also holds an MSc in Immunology and Regenerative Medicine from Mansoura University in Egypt and a Master's degree in Public Health from Aix Marseille University in France. His expertise is recognised internationally, and he is an active member of the International Society of Nephrology, the African Association of Nephrology, the Board of Directors of the Eastern African Health Research Commission and several regional and international health expert working groups. Joseph is also Chairman of the National Ethics Committee and the National Commission for Science, Technology and Innovation in Burundi. Joseph is the author and co-author of several articles on communicable and non-communicable diseases and other public health topics. He is currently the Principal Investigator for research projects funded by EDCTP (IMPRIMA project and others), USAID, ENABEL, amongst others.

Julie Nguyen N. P. (ORCID 0000-0002-0726-4119) holds a Doctorate in Pharmacy and Science from the Faculty of Pharmacy at Louis Pasteur University in Strasbourg (France). Specialising in industrial pharmacy, infectious and tropical diseases, and molecular pharmacological modelling, she completed her D.E.A. (Master's degree) and PhD at the National Museum of Natural History in Paris in Chemistry and Activity of Natural Substances. Her thesis focused on anti-malarial plants in Vietnam. As part of her research, Julie lived in Vietnam for four years, establishing and leading the Clinical Pharmacology Laboratory of the Oxford University Clinical Research Unit in Ho Chi Minh City. Specialising in pharmacokinetic studies, Julie obtained a Master's degree in clinical research from the University of Oxford in the United Kingdom in 2012. She then lived in Bangkok, Thailand for eight years, where she initiated the development of the clinical quality system for the MORU Clinical Trials Department. Upon her return to France, Julie joined the ReMeD as a Project Manager on the DPP and IMPRIMA projects, working with Prof Bob Taylor.

Lovasoa Rasoanandrasana is a specialist in financial management and health logistics. She is currently responsible for general affairs and logistics at the National Centre for Pharmaceutical Research Applications (CNARP).

Mamy Jean Jacques Razafimahatratra, PhD (ORCID 0000-0002-7238_5179), is a specialist in public health and a socio-anthropologist with extensive field research experience in health and health anthropology. He is currently head of the research division at the National Institute of Public and Community Health (INSP) in Antananarivo, Madagascar.

Maximilienne Kialozafy is a biologist specialising in biochemistry, biodiversity and health. She is particularly interested in infectious and parasitic diseases and currently works at the National Centrefor Pharmaceutical Research Applications (CNARP) as a biologist in the clinical trials department andon the IMPRIMA project.

Omega Raobela holds a Specialised Master's degree in Health Sciences, with a focus on Public Health, and a FETP-SEGA ONE HEALTH qualification. She works for the National Malaria Control Programme (PNLP) as programme manager. Since 2011, she has been involved in clinical research on malaria as an investigator.

Pascal Millet (PhD, HDR) holds a Doctorate in Science from Pierre and Marie Curie University in Paris VI (France). After completing his doctorate, Pascal worked in Atlanta (GA, USA) at the Centres for Disease Control (CDC) as a research assistant, head of the reference centre for imported malaria and as an assistant professor at Emory University. He then travelled to Gabon where he served as director of research at the International Medical Research Centre in Franceville (CIRMF). Upon his return to France, Pascal workd with Pierre Fabre Médicament as a malaria project manager. He also founded the Technology Transfer Office at the University of Bordeaux. He then served as Director for the Aquitaine Regional Business Incubator and was appointed senior lecturer and hospital practitioner at the University/University Hospital of Bordeaux. As part of his academic activities, he was seconded to the University of Health Sciences in Phnom Penh (Cambodia) as an advisor to the rector, joining the Chembiopharm team (INSERM Unit 1212 – CNRS Unit 5320) in Bordeaux. Pascal Millet has conducted extensive research on parasitic diseases, particularly malaria. He has been part of vaccine trials on primates, established epidemiological study sites, and led research on malaria, filariasis and trypanosomiasis in Gabon. At the University of Bordeaux, Pascal devoted his work to innovative therapies, contributing to the development of strategies for controlling neglected tropical diseases. He initiated the development of the antimalarial drug artesunate-amodiaquine (ASAQ®), marketed by SANOFI. He is the author and co-author of more than 130 scientific publications in peer reviewed international journals.

Rianasoambolanoro Rakotosaona, PhD, HDR (ORCID 0000-0003-4310-8065), is the director of the National Centre for Pharmaceutical Research Applications (CNARP). A senior lecturer at the École Supérieure Polytechnique of the University of Antananarivo, Rianasoambolanoro specialises in medicinal chemistry.

Rosine Sidnoma Kabore is the communications officer for the Groupe de Recherche Action en Santé (GRAS). With a bachelor's degree in communication for development and a master's degree in international cooperation and humanitarian aid, she has built a rich and varied career working with vulnerable communities, humanitarian organisations and national institutions. Her experience as a multimedia journalist, combined with her role as communications officer and project coordinator in the community development sector, has helped to strengthen her expertise in institutional and humanitarian communications, particularly through the development of national awareness raising strategies for the fight against HIV/AIDS. Rosine has completed numerous strategic training courses in advocacy and leadership (YALI Dakar), as well as in digital marketing and fundraising techniques. She stands out for her versatility and analytical skills. Her career path demonstrates a deep motivation to contribute to development through communication for behavioural change.

Sheila Varadan (ORCID 0000-0002-4610-5735) is an assistant professor in Children's Rights and Global Health in a joint appointment between the Department of Health and Children's Rights at Leiden Law School and the Leiden Centre for African Studies (ASCL). She is a founding member of the Leiden University Network for Health in Africa (LUNHA), an interdisciplinary research centre focusing on equity and justice in global health. She is also a teaching fellow at the University of Oxford, where she has been teaching on the MSc in International Health Sciences and Tropical Medicine since 2020.

Sodiomon B. Sirima is Senior Researcher and Managing Director of Groupe de Recherche Action en Santé (GRAS), a private health research institute established in 2008. Sodiomon is accredited by the Ministry of Science and Technology of Burkina Faso and is actively working in partnership with the Ministry of Health. Over the past 25 years, Sodiomon has led several clinical studies and research activities on the implementation of treatments for infectious diseases, particularly malaria. Sodiomon has authored over 170 peer-reviewed scientific publications, and is a leading researcher and expert in the field of malaria, both nationally and internationally. His current research focuses on the clinical evaluation of new tools for combating infectious diseases (such as vaccine candidates and drugs) as well as epidemiological studies.

Thibault Vallet, PhD, is a research scientist and project leader at ClinSearch. He is the co-inventor of CAST – ClinSearch Acceptability Score Test®, a novel data driven approach facilitating medicine design for optimal acceptability in vulnerable populations. CAST is used as part of this EDCTP project aiming to develop a paediatric primaquine formulation. Thibault holds a MSc in sensory science from the University of Lyon, and after working to prevent criminal misuse of psychoactive drugs for the French medicines agency, he joined ClinSearch and started his PhD on medicine acceptability at Arts et Métiers ParisTech in 2014. Seven years later, this innovative research project received a number of prizes and honours, inter alia, from the French Academy of Pharmaceutical Sciences, the French Sensory Science Society and the European Paediatric Formulation Initiative (EuPFI) consortium. As research scientist and project leader at ClinSearch, Thibault coordinates international research projects, and supports pharmaceutical companies in designing and conducting clinical trials and RWE studies in order to demonstrate the acceptability of their medications and meet regulatory requirements. Today, Thibault is analysing meta-data from Japan, India, Norway, Germany, Morocco, and elsewhere. This represents a fresh opportunity to employ CAST to better understand the influence of these different cultures on medicines acceptability.

Tovonahary Angelo Rakotomanga is a biologist specialising in clinical research and laboratory diagnostics who works for the Madagascan Ministry of Public Health. A WHO-certified expert in malaria microscopy, he has extensive experience in molecular analysis, particularly in relation to malaria.
Passionate about research, he is committed to improving the quality of biological analyses, which is why he joined the IMPRIMA project.